Flubendazole

BRAND NAMES

Flubendazole is an anthelmintic (deworming) medication available under several brand names for both human and veterinary use. In humans, it is commonly sold as Fluvermal in Europe and as Zelcom in other regions to treat intestinal worm infections. For veterinary purposes, it is marketed under names such as Flubenol for the treatment of parasitic infections in animals.

 MECHANISM OF ACTION

Flubendazole is a benzimidazole-class anthelmintic that works by binding to β-tubulin in parasites, preventing the formation of microtubules. Microtubules are essential components of the parasite’s cytoskeleton, and their disruption interferes with cellular structure and function. By impairing the cytoskeleton, flubendazole also blocks the parasite’s ability to absorb nutrients, especially glucose, which is critical for energy production. This energy depletion weakens the parasite and eventually leads to its death. This mechanism makes flubendazole highly effective against a range of intestinal worms, including roundworms, hookworms, and whipworms, while generally having minimal impact on human cells, as it selectively targets parasitic β-tubulin.

PHARMACOKINETICS

Absorption

Flubendazole is poorly absorbed when taken orally. Its absorption can be improved by consuming fatty meals and further optimized using nano-formulations. 

Distribution

The drug is highly lipophilic and distributes rapidly throughout the body, including the brain, where tissue concentrations can exceed those in plasma. 

Metabolism

Flubendazole is extensively metabolized in the liver and intestinal wall, mainly into reduced-flubendazole (FLU-R) and hydrolyzed-flubendazole (FLU-H). 

Elimination

It is primarily excreted through feces, with a relatively short half-life of approximately 6 hours in some models.

PHARMACODYNAMICS

Flubendazole is a benzimidazole-class anthelmintic that targets parasites by binding to β-tubulin, preventing tubulin polymerization and disrupting microtubule-dependent intracellular transport. This action rapidly damages the parasite’s absorptive tissues, causing metabolic collapse and death, while showing strong selectivity for parasite tubulin over that of mammals.

ADMINISTRATION

Flubendazole is a benzimidazole-class anthelmintic typically given orally, either mixed into feed or as a paste, to treat parasitic infections in animals. It is frequently administered to pigs and poultry to manage and prevent helminth infestations.. Although primarily a veterinary drug, experimental studies in animals have demonstrated its effectiveness against parasites when administered at appropriate doses.

DOSAGE AND STRENGTH

Flubendazole is available in various formulations and dosages for both human and veterinary use. In humans, it is typically administered orally at a dose of 100 mg, once or twice daily for 1–3 days, depending on the type of intestinal worm infection. Pediatric doses vary according to age and weight, and the medication is commonly available as tablets, chewable forms, or oral suspensions. In veterinary medicine, flubendazole is mainly used in pigs and poultry to control helminth infections, given orally via feed or paste. Doses usually range from 2 to 10 mg/kg of body weight per day for 1–5 days, depending on the species and severity of the infestation. Formulations for animals include powders, pastes, and medicated feeds, with concentrations tailored to the target species.

DRUG INTERACTIONS

Flubendazole, a benzimidazole-class anthelmintic, primarily interacts with drugs that influence liver enzymes (CYP450), which can affect its metabolism. Its effectiveness may be reduced when taken with enzyme inducers such as phenytoin or carbamazepine, while concurrent use with enzyme inhibitors like cimetidine can increase the risk of side effects. Flubendazole may also have interactions with certain anticancer medications.

FOOD INTERACTIONS

Albendazole should be taken with a high-fat meal to enhance its absorption and overall effectiveness, as fats improve its solubility. Taking it on an empty stomach can result in suboptimal drug levels. Grapefruit juice should be avoided, as it may interfere with the medication’s action.

CONTRAINDICATIONS

Flubendazole, a benzimidazole anthelmintic, is primarily used to treat parasitic infections. It is contraindicated in individuals with a known allergy to flubendazole or other benzimidazoles, during pregnancy—particularly in the first trimester—and in those with severe liver disease. Use with caution is recommended for patients with liver impairment or blood disorders.

SIDE EFFECTS 

• Common/Mild: 

  • Nausea 

  • Diarrhea 

  • Abdominal pain 

• Rare/Serious: 

  • Allergic reactions (rash, swelling) 

  • Liver dysfunction 

  • Blood count changes (leukopenia, anemia) 

OVER DOSE

An overdose of flubendazole in animals can cause serious toxicity, affecting the liver, kidneys, and bone marrow. Common signs include lethargy, loss of appetite, and decreased performance. There is no specific antidote, so management relies on symptomatic and supportive care.

TOXICITY

Flubendazole toxicity can occur in both humans and animals, usually as a result of overdose or improper use. In humans, it is generally mild, presenting with symptoms such as nausea, vomiting, abdominal pain, diarrhea, headache, and dizziness, though rare serious effects like allergic reactions, liver impairment, or blood abnormalities (e.g., leukopenia, anemia) may occur. In animals, overdose can cause more severe toxicity, affecting the liver, kidneys, and bone marrow, with common signs including lethargy, reduced appetite, and poor growth or performance. There is no specific antidote for flubendazole toxicity, so treatment focuses on stopping the drug and providing supportive care, such as fluid therapy, monitoring organ function, and managing any blood-related complications.